Morgan Stanley Starts Pacific Shuanglin Bio-pharmacy at Overweight With 37 Yuan Price Target
Morgan Stanley Starts Pacific Shuanglin Bio-pharmacy at Overweight With 37 Yuan Price Target
摩根士丹利增持启动太平洋双林生物制药，目标股价为37元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册